Ashwagandha-Induced Gastric Upset in Post-Covid Patient-A Case Report and Brief Review of the Literature
Journal of Complementary and Alternative Medical Research,
Adverse drug reporting of herbal drugs is less common as they are generally considered as safe. It is also very common to use self-medication by people in the case of herbal drugs. But many times, mild to severe events have been seen with the use of herbal or ayurvedic medicines. We have reported a case of post-covid patient, who was having complained of headache, body ache, lethargy, backache, generalized weakness and excessive sweating since one weak. Patient had past history of hospitalization due to COVID-19 moderate pneumonia one month back. Patient also had history of type-2 diabetes mellitus, hypertension and dyslipidemia and was taking anti-diabetic and anti-hypertensive medications continuously. Ashwagandha powder (Withania somnifera), Maha yogaraj guggulu (herbal anti-inflammatory) and Syrup Amynity Plus (herbal immune-booster) were prescribed for these complain. Conversely, moderate severity adverse reaction like nausea, vomiting, diarrhea, and abdominal cramps were noted after the intake of suspected drug i.e. ashwagandha powder. Nevertheless, symptoms were relieved after the de-challenge. This shows a temporal relation of the event with the suspected drug. One more possibility of drug-drug interaction in this case cannot be ruled out completely. Causality assessment was done for this adverse event and it was considered as the “probable” category of the adverse event in WHO causality classification.
- Adverse drug reaction
- withania somnifera
- case report
How to Cite
DOI:10.2165/00002018-200225140-00003. PMID: 12408732.
Ajanal M, Prasad BS. A combined administration of Aragvādādi kaṣāyam and Syrup Talekt induced skin rashes. AncSci Life. 2014 Jan;33(3):172-5.
DOI:10.4103/0257-7941.144622. PMID: 25538353; PMCID: PMC4264306.
Ajanal M, Kadam A, Nayak SU. Skin rash on site of application of Dashanga Lepa (polyherbal formulation): A rare and unexpected drug reaction. AncSci Life. 2012;31(3):129-31.
DOI: 10.4103/0257-7941.103193. PMID: 23284219; PMCID: PMC3530337.
Mongolu S, Sharp P. Acute abdominal pain and constipation due to lead poisoning. Acute Med. 2013;12(4):224-6. PMID: 24364054.
Jadav HR, Ghetiya H, Prashanth B, Galib, Patgiri BJ, Prajapati PK. Ayurvedic management of adverse drug reactions with ShvitraharaVarti. Ayu. 2013;34(2): 189-92.
DOI:10.4103/0974-8520.119676. PMID: 24250129; PMCID: PMC3821249.
Channabasappa SM, Gupta B, Dharmappa S. VajraBhasma, Ayurvedic medicine: a rare and unusual cause of Lyell's syndrome and its successful management. BMJ Case Rep. 2020;13(10):e237891.
DOI:10.1136/bcr-2020-237891. PMID: 33127708; PMCID: PMC7604812.
Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5(4):334-46. PMID: 10956379.
Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020 Apr;40(4):825-829.
DOI:10.1111/liv.14393. Epub 2020 Feb 11. PMID: 31991029; PMCID: PMC8041491.
Sehgal VN, Verma P, Bhattacharya SN. Fixed-drug eruption caused by ashwagandha (Withania somnifera): a widely used Ayurvedic drug. Skinmed. 2012;10(1):48-9. PMID: 22324179.
Mohan A, Menon A, Chacko J, Mohan P, Robin DT. An Eye into the Allegations about Ashwagandha. Liver Int. 2020 Aug;40(8):2034-2035.
DOI:10.1111/liv.14459. Epub 2020 Apr 21. PMID: 32267603.
Singh, S., Javed, D., Mukherjee, S., Mittal, R., Chourasia, N., Agrawal, A., Kotnis, A. (2021). Therapeutic Potential of Traditional Indian Herbal Medicine in COVID-19: A Narrative Review. Hospital Practices and Research, 6(2), 42-50.
Van der Hooft CS, Hoekstra A, Winter A, de Smet PA, Stricker BH. Thyreotoxicosenagebruik van Ashwagandha [Thyrotoxicosis following the use of ashwagandha]. Ned Tijdschr Geneeskd. 2005;149(47):2637-8. Dutch. PMID: 16355578.
Inagaki K, Mori N, Honda Y, Takaki S, Tsuji K, Chayama K. A case of drug-induced liver injury with prolonged severe intrahepatic cholestasis induced by Ashwagandha. Kanzo 2017;58:448-54. Not in PubMed.
Liver Tox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.Ashwagandha.[Updated 2019 May 2].
Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B. Evaluating higher doses of Shunthi - Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project. J Ayurveda Integr Med. 2012;3(1): 38-44.
DOI:10.4103/0975-9476.93948. PMID: 22529679; PMCID: PMC3326794.
Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder &SidhMakardhwaj) in rheumatoid arthritis patients: a pilot prospective study. Indian J Med Res. 2015;141(1):100-6.
DOI:10.4103/0971-5916.154510. PMID: 25857501; PMCID: PMC4405924.
Choudhary D, Bhattacharyya S, Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. J Diet Suppl. 2017 Nov 2;14(6):599-612.
DOI:10.1080/19390211.2017.1284970. Epub 2017 Feb 21. PMID: 28471731.
Choudhary D, Bhattacharyya S, Joshi K. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial. J Evid Based Complementary Altern Med. 2017;22(1):96-106.
DOI:10.1177/2156587216641830. Epub 2016 Apr 6. PMID: 27055824; PMCID: PMC5871210.
Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3): 255-62.
DOI:10.4103/0253-7176.106022. PMID: 23439798; PMCID: PMC3573577.
Verma N, Gupta SK, Tiwari S, Mishra AK. Safety of Ashwagandha Root Extract: A Randomized, Placebo-Controlled, study in Healthy Volunteers. Complement Ther Med. 2021;57:102642.
DOI:10.1016/j.ctim.2020.102642.Epub2020 Dec 15. PMID: 33338583.
Kotecha R. The journey with COVID- 19: Initiatives by Ministry of Ayush J Ayurveda Integr Med. 2021; 12(1):1-3.
DOI:10.1016/j.jaim.2021.03.009. PMID: 33812534; PMCID: PMC8011587.
Abstract View: 112 times
PDF Download: 23 times